Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration.

doi:10.1378/chest.105.5.1406

Back to search

Article

Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration.

Chest - 1 May 1994

Barker A F, Siemsen F, Pasley D, D'Silva R, Buist A S

Abstract excerpt

This retrospective chart review describes the efficacy and safety of long-term administration of intravenous alpha1-antitrypsin (AAT) in 14 patients with hereditary AAT deficiency and COPD. During the 12- to 48-month observation period, 12 to 14 patients had stabilization of functional status; 4...

Topics

Adult
Female
Forced Expiratory Volume
Humans
Infusions, Intravenous
Lung Diseases, Obstructive
Male
Middle Aged
Phenotype
Retrospective Studies
Vital Capacity
alpha 1-Antitrypsin
alpha 1-Antitrypsin Deficiency

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.